FITC Plus Anti-Human KIM-1/HAVCR1 Rabbit Recombinant Antibody

KIM-1/HAVCR1 Uni-rAbTM Recombinant Antibody for FC
Cat No. FITC-98238

产品说明书

CloneNo. 242001E8

宿主/亚型

Rabbit / IgG

种属反应性

human

应用

FC

缓冲液配方:  PBS and Azide
PBS and Azide
规格: 

-/ -


经过测试的应用

Positive FC detected inHuH-7 cells

推荐稀释比

应用推荐稀释比
This reagent has been pre-titrated and tested for flow cytometric analysis. The suggested use of this reagent is 5 ul per 10^6 cells in a 100 µl suspension or 5 ul per 100 µl of whole blood.
Sample-dependent, Check data in validation data gallery.

产品信息

FITC-98238 targets KIM-1/HAVCR1 in applications and shows reactivity with human samples.

经测试应用 FC Application Description
经测试反应性 human
免疫原 Recombinant protein 种属同源性预测
宿主/亚型 Rabbit / IgG
抗体类别 Recombinant
产品类型 Antibody
全称 hepatitis A virus cellular receptor 1
别名
计算分子量39kDa
GenBank蛋白编号NM_001173393.3
基因名称 HAVCR1
Gene ID (NCBI) 26762
偶联类型 FITC Plus Fluorescent Dye
最大激发/发射波长495 nm / 524 nm
形式 Liquid
纯化方式Protein A purification
UNIPROT IDQ96D42
储存缓冲液 PBS with 0.09% sodium azide and 0.5% BSA , pH 7.3
储存条件Store at 2-8°C. Avoid exposure to light. Stable for one year after shipment.

背景介绍

Kidney injury molecule 1 (KIM-1), also known as Hepatitis A virus cellular receptor 1 (HAVCR1), CD365, or T-cell immunoglobulin and mucin domain 1 (TIM-1), is a class I integral membrane glycoprotein, with an ectodomain containing Ig-like domain and a mucin domain. KIM-1 acts as a membrane receptor for hepatitis A virus (HAV) (PMID: 9658108; 8861957). KIM-1 provides a costimulatory signal for T cell activation and inhibits the development of peripheral tolerance (PMID: 16284246; 15793575). KIM-1 may be involved in the regulation of asthma and allergic diseases (PMID: 14534576). It has been reported that KIM-1 is shed into urine after acute kidney damage and is a marker of renal tubular injury (PMID: 14600030).

实验方案

Product Specific Protocols
FC protocol for FITC Plus KIM-1/HAVCR1 antibody FITC-98238Download protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...